Patients should be the tipping point of individualizing breast cancer surgery: Commentary on 'Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges'

被引：6
|
作者：
Heil, J. [1 ]
Pfob, A. [1 ]
机构：
[1] Heidelberg Univ, Dept Gynecol, Heidelberg, Germany
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷 / 09期
关键词：
D O I：
10.1016/j.annonc.2020.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1264 / 1264
页数：1
相关论文
共 50 条
  • [41] Important considerations prior to elimination of breast cancer surgery after neoadjuvant systemic therapy: Listening to what our patients want
    Caballero, C.
    Piccart, M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (08) : 1083 - 1084
  • [42] De-escalating Breast Cancer Surgery-Where Is the Tipping Point?
    Morrow, Monica
    Winer, Eric P.
    [J]. JAMA ONCOLOGY, 2020, 6 (02) : 183 - 184
  • [43] Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy
    Endo, Yuka
    Kotani, Haruru
    Tamura, Nobuko
    Tanaka, Kiyo
    Kudo, Chiho
    Sawaki, Masataka
    Hattori, Masaya
    Yoshimura, Akiyo
    Kataoka, Ayumi
    Nozawa, Kazuki
    Ozaki, Yuri
    Isogai, Ayaka
    Komaki, Rie
    Nakakami, Akira
    Kureyama, Nari
    Kusudo, Maho
    Hosoda, Waki
    Kawabata, Hidetaka
    Iwata, Hiroji
    [J]. BREAST CANCER, 2024,
  • [44] Predictive factors of conservative breast surgery after neoadjuvant chemotherapy for breast cancer
    Pilloy, J.
    Fleurier, C.
    Chas, M.
    Bedouet, L.
    Jourdan, M. L.
    Arbion, F.
    Body, G.
    Ouldamer, L.
    [J]. GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (09): : 466 - 471
  • [45] Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients
    Omarini, C.
    Guaitoli, G.
    Noventa, S.
    Andreotti, A.
    Gambini, A.
    Palma, E.
    Papi, S.
    Tazzioli, G.
    Balduzzi, S.
    Dominici, M.
    Cascinu, S.
    Piacentini, F.
    [J]. EJSO, 2017, 43 (04): : 613 - 618
  • [46] Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer
    Piacentini, F.
    Filieri, M. E.
    Grizzi, G.
    Omarini, C.
    Maur, M.
    Guaitoli, G.
    Tazzioli, G.
    Madrigali, S.
    Caggia, F.
    Luppi, G.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 4 - 5
  • [47] Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients
    Mueller, Carolin
    Juhasz-Boess, Ingolf
    Schmidt, Gilda
    Jungmann, Peter
    Solomayer, Erich-Franz
    Breitbach, Georg-Peter
    Juhasz-Boess, Stephanie
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (04) : 1055 - 1059
  • [48] Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients
    Carolin Müller
    Ingolf Juhasz-Böss
    Gilda Schmidt
    Peter Jungmann
    Erich-Franz Solomayer
    Georg-Peter Breitbach
    Stephanie Juhasz-Böss
    [J]. Archives of Gynecology and Obstetrics, 2020, 301 : 1055 - 1059
  • [49] Factors Influencing the Time to Surgery after Neoadjuvant Chemotherapy in Breast Cancer Patients
    Mueller, Carolin
    Juhasz-Boess, Stephanie
    Schmidt, Gilda
    Jungmann, Peter
    Solomayer, Erich-Franz
    Breitbach, Georg-Peter
    Juhasz-Boess, Ingolf
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 8 - 8
  • [50] High pathological grade might discourage early invasive breast cancer patients who have a pathologic complete response to neoadjuvant systemic therapy from eliminating breast surgery
    Li, Chaofan
    Wang, Yusheng
    Liu, Mengjie
    Qu, Jingkun
    Zhang, Shuqun
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (02) : 1268 - 1270
12345